Thursday, April 20, 2017 11:43:06 PM
That why I argued Clipstream has some option value in the early Jan article, or compared it to a biotech in the April article. Just like a biotech, you don't know if it will be successful, and often you have to wait a long time, but the payoff can be huge.
Your assumption is that it won't move before they sell. You might be right, I dunno. But it could also be that the stock starts to move when more people see that the quality of the demo's is getting good enough, just like biotech can move well before final FDA approval. I really do not know whether this will happen, nor do I know whether Clipstream will ever be good enough, but under 20 cents, given the fairly low risks and given the potentially huge payoff, I simply liked the situation.
I wouldn't entirely discount the generic streaming hosting opportunity either, by the way.
Nothing is guaranteed, but a huge pay-off in case Clipstream does work well enough to sell isn't unlikely:
- Streaming video is a multi-billion dollar market, growing at a high rate
- Clipstream has fairly unique capabilities that are good for a sliver of that market
- Shhh, don't tell anyone, but since it's automated it's high fixed cost and therefore high margin business.
- Even only a tiny sliver of a multi-billion dollar market quickly adds to the accounts of an $11M market cap company.
So, bar some catastrophe, I thought in December, my downside is perhaps 5 cents, but my upside is potentially pretty good. I hadn't followed it for years but noted the low price and noted that they were trying a new codec and that everybody had puked it out and given up on it. That sort of seemed an interesting risk/reward.
Recent DSNY News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/27/2024 03:14:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 08:18:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 02:16:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/28/2023 11:01:54 AM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:08:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:01:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:57:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:56:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:49:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:44:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:28:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 10:04:12 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM